Formulation of 2- (4-chlorophenyl) -N-((2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline-5-yl) methyl) -2,2-difluoroacetamide

摘要

Compound 1 (2- (4-chlorophenyl) -N-((2-2,6-dioxopiperidin-3-yl) -1-oxoisoindoline-5-yl) methyl) -2,2-difluoroacetamide) Or a lyophilization of a stereoisomer or a mixture of stereoisomers, pharmaceutically acceptable salts, tautomers, prodrugs, solvates, hydrates, co-crystals, inclusion compounds, or polymorphs thereof Formulations are provided herein. Also provided herein are methods of using the formulations and dosage forms for treating, managing and / or preventing cancer. [Selection] Figure 1